A substrate-based ontology for human solute carriers.


Journal

Molecular systems biology
ISSN: 1744-4292
Titre abrégé: Mol Syst Biol
Pays: England
ID NLM: 101235389

Informations de publication

Date de publication:
07 2020
Historique:
received: 22 04 2020
revised: 24 06 2020
accepted: 26 06 2020
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 15 7 2021
Statut: ppublish

Résumé

Solute carriers (SLCs) are the largest family of transmembrane transporters in the human genome with more than 400 members. Despite the fact that SLCs mediate critical biological functions and several are important pharmacological targets, a large proportion of them is poorly characterized and present no assigned substrate. A major limitation to systems-level de-orphanization campaigns is the absence of a structured, language-controlled chemical annotation. Here we describe a thorough manual annotation of SLCs based on literature. The annotation of substrates, transport mechanism, coupled ions, and subcellular localization for 446 human SLCs confirmed that ~30% of these were still functionally orphan and lacked known substrates. Application of a substrate-based ontology to transcriptomic datasets identified SLC-specific responses to external perturbations, while a machine-learning approach based on the annotation allowed us to identify potential substrates for several orphan SLCs. The annotation is available at https://opendata.cemm.at/gsflab/slcontology/. Given the increasing availability of large biological datasets and the growing interest in transporters, we expect that the effort presented here will be critical to provide novel insights into the functions of SLCs.

Identifiants

pubmed: 32697042
doi: 10.15252/msb.20209652
pmc: PMC7374931
doi:

Substances chimiques

Amino Acids 0
Membrane Transport Proteins 0

Banques de données

GEO
['GSE153034']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e9652

Informations de copyright

© 2020 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Mol Syst Biol. 2020 Jul;16(7):e9652
pubmed: 32697042
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6859-64
pubmed: 23569283
Bioinformatics. 2010 Oct 15;26(20):2647-8
pubmed: 20829444
Protein Sci. 2010 Mar;19(3):412-28
pubmed: 20052679
Nat Rev Drug Discov. 2016 Feb;15(2):143
pubmed: 26837595
Mol Aspects Med. 2013 Apr-Jun;34(2-3):95-107
pubmed: 23506860
Cancer Treat Rev. 2012 Oct;38(6):726-36
pubmed: 22342103
Nucleic Acids Res. 2015 Jan;43(Database issue):D204-12
pubmed: 25348405
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Nat Rev Drug Discov. 2015 Aug;14(8):543-60
pubmed: 26111766
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10988-E10997
pubmed: 30373828
Cell. 2015 Jul 30;162(3):478-87
pubmed: 26232220
PLoS Genet. 2015 Apr 07;11(4):e1005158
pubmed: 25849282
Nat Rev Drug Discov. 2020 Jul;19(7):429-430
pubmed: 32265506
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Biol Cell. 2018 Dec 15;29(26):3183-3200
pubmed: 30354837
PLoS Genet. 2019 Sep 25;15(9):e1008208
pubmed: 31553721
Methods Mol Biol. 2017;1654:55-75
pubmed: 28986783
Amino Acids. 2009 May;37(1):79-88
pubmed: 19009228
Genome Res. 2016 Oct;26(10):1397-1410
pubmed: 27470110
Brief Bioinform. 2015 Nov;16(6):1069-80
pubmed: 25863278
Cell. 2013 Jul 18;154(2):403-15
pubmed: 23870128
J Nutr Biochem. 2013 Oct;24(10):1697-708
pubmed: 23643525
Front Pharmacol. 2018 Sep 07;9:1011
pubmed: 30245630
Trends Pharmacol Sci. 2017 Mar;38(3):305-315
pubmed: 27939446
Bioinformatics. 2005 Aug 15;21(16):3439-40
pubmed: 16082012
Cell Syst. 2018 Feb 28;6(2):230-244.e1
pubmed: 29428416
Science. 2018 Nov 16;362(6416):
pubmed: 30442778

Auteurs

Eva Meixner (E)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Ulrich Goldmann (U)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Vitaly Sedlyarov (V)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Stefania Scorzoni (S)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Manuele Rebsamen (M)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Enrico Girardi (E)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Giulio Superti-Furga (G)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH